2026 ICD-10-CM Diagnosis Code E70.39Other specified albinism

ICD-10-CM Codes›E00–E89›E70-E88›E70

ICD-10-CM E70.39
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

E70.39 is a billable ICD-10-CM diagnosis code for other specified albinism. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified nutritional and metabolic disorders.

Code Identity

ICD-10-CM Code
E70.39
Billable Status
Yes — Valid for Submission
Code Describes
Other specified albinism
Short Description
Other specified albinism
Same as the full description in the CMS dataset.
Parent Code
E70.3
Albinism

Code Classification

ChapterE00–E89Endocrine, nutritional and metabolic diseases
SectionE70-E88Metabolic disorders
CategoryE70Disorders of aromatic amino-acid metabolism
This CodeE70.39Other specified albinism

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Albinism-deafness syndrome of Tietz
  • Dystopia canthorum
  • Griscelli syndrome type 1
  • Griscelli syndrome type 3
  • Hypopigmentation-immunodeficiency disease
  • Immunodeficiency associated with multiple organ system abnormalities
  • Immunodeficiency with major anomalies
  • Phylloid hypomelanosis
  • Piebald trait with neurologic defects syndrome
  • Piebaldism
  • Profound hearing loss
  • Profound sensorineural hearing loss
  • Sensorineural hearing loss of bilateral ears
  • Waardenburg syndrome
  • Waardenburg syndrome type 3
  • Ziprkowski-Margolis syndrome

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Piebaldism

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Albinism, albino
      • other specified
    • Piebaldism

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR END016
Other specified and unspecified nutritional and metabolic disorders
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Waardenburg Syndrome

    rare, autosomal dominant disease with variable penetrance and several known clinical types. characteristics may include depigmentation of the hair and skin, congenital deafness, heterochromia iridis, medial eyebrow hyperplasia, hypertrophy of the nasal root, and especially dystopia canthorum. the underlying cause may be defective development of the neural crest (neurocristopathy). waardenburg's syndrome may be closely related to piebaldism. klein-waardenburg syndrome refers to a disorder that also includes upper limb abnormalities.

  • Piebaldism

    autosomal dominant, congenital disorder characterized by localized hypomelanosis of the skin and hair. the most familiar feature is a white forelock presenting in 80 to 90 percent of the patients. the underlying defect is possibly related to the differentiation and migration of melanoblasts, as well as to defective development of the neural crest (neurocristopathy). piebaldism may be closely related to waardenburg syndrome.

  • Piebaldism

    a rare, autosomal dominant disorder caused usually by mutations in the kit gene. it is characterized by abnormalities in the development of melanocytes. it presents with multiple symmetrical hypopigmented or depigmented patches of skin and a midline patch of white hair.

Patient EducationClinical

Skin Pigmentation Disorders

Pigmentation means coloring. Skin pigmentation disorders affect the color of your skin. Your skin gets its color from a pigment called melanin. Special cells in the skin make melanin. When these cells become damaged or unhealthy, it affects melanin production. Some pigmentation disorders affect just patches of skin.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert E70.39 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
270.2 Arom amin-acid metab NEC
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About E70.39Overview

Is E70.39 (Albinism) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report other specified albinism on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What is the ICD-9 equivalent of E70.39?

Under the General Equivalence Mappings, other specified albinism converts to ICD-9-CM 270.2 (arom amin-acid metab NEC). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.